Sharon Shacham's Net Worth

$11.2 Million

Estimate Recalculated Nov 7, 2024 12:13PM EST

Who is Sharon Shacham?

Sharon Shacham has an estimated net worth of $11.2 Million. This is based on reported shares across multiple companies, which include Karyopharm Therapeutics Inc., and Acrivon Therapeutics, Inc..

SEC CIK

Sharon Shacham's CIK is 0001588438

Past Insider Trading and Trends

2020 was Sharon Shacham's most active year for acquiring shares with 19 total transactions. Sharon Shacham's most active month to acquire stocks was the month of January. 2020 was Sharon Shacham's most active year for disposing of shares, totalling 34 transactions. Sharon Shacham's most active month to dispose stocks was the month of January. 2019 saw Sharon Shacham paying a total of $190,492.50 for 370,900 shares, this is the most they've acquired in one year. In 2014 Sharon Shacham cashed out on 130,000 shares for a total of $4,653,635.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Karyopharm Therapeutics Inc. (KPTI) Snapshot price: $0.77

Chief Scientific Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.68%
60K
—
—
958.13K
Mar 29
Form 4
+0.53%
8.55K
$10.24
-$127,477.34
1.61M
Feb 28
Form 4
-1.12%
-18.17K
$12.12
-$220,245.81
1.6M
Feb 17
Form 4
-0.82%
-13.47K
$9.86
-$132,851.00
1.62M
Feb 7
Form 4
-0.56%
-4.00K
$12.39
-$49,552.80
714.83K
Scheduled
Mar 18
Form 4
+7.50%
114.4K
—
—
1.64M
Feb 25
Form 4
-1.39%
-18.99K
$14.83
-$281,644.48
1.35M
Feb 18
Form 4
+2.27%
30.36K
$15.52
-$205,518.12
1.37M
Feb 11 - Feb 15
Form 4
+2.18%
28.6K
—
—
1.34M
Feb 5
Form 4
—
0
$7.46
-$111,435.00
756.49K
Scheduled
Oct 12
Form 4
—
0
$7.52
-$22,106.26
756.49K
Scheduled
Aug 17
Form 4
—
0
$9.73
-$145,475.25
756.49K
Scheduled
Jul 15
Form 4
—
0
$12.01
-$217,746.21
1.31M
Scheduled
Jul 9 - Jul 10
Form 4
—
0
$10.02
-$149,752.50
756.49K
Scheduled
Jun 22
Form 4
—
0
$8.20
-$122,531.81
756.49K
Scheduled
Jun 15
Form 4
—
0
$11.53
-$203,409.75
1.31M
Scheduled
Jun 9 - Jun 10
Form 4
—
0
$9.68
-$289,345.50
756.49K
Scheduled
May 15 - May 18
Form 4
—
0
$12.19
-$223,134.00
1.31M
Scheduled
May 7
Form 4
—
0
$12.19
-$297,479.00
1.31M
Scheduled
Apr 8 - Apr 9
Form 4
—
0
$13.56
-$352,340.57
1.31M
Scheduled
Mar 9 - Mar 10
Form 4
-1.33%
-17.63K
$16.48
-$290,641.82
1.31M
Feb 19
Form 4
+3.39%
43.6K
—
—
1.33M
Feb 15
Form 4
—
0
$10.97
-$248,581.00
1.29M
Scheduled
Feb 10 - Feb 11
Form 4
—
0
—
—
0
Feb 5
Form 4
-2.62%
-34.63K
$11.82
-$282,545.00
1.29M
Scheduled
Dec 19 - Jan 9
Form 4
—
0
$10.63
-$235,066.00
1.26M
Scheduled
Dec 9 - Dec 10
Form 4
—
0
$9.73
-$198,824.00
1.26M
Scheduled
Nov 8 - Nov 11
Form 4
—
0
$8.38
-$144,960.00
1.26M
Scheduled
Nov 1
Form 4
—
0
$8.38
-$144,960.00
1.26M
Scheduled
Sep 16
Form 4
—
0
—
—
0
Feb 15
Form 4
—
0
$5.13
-$127,411.25
731.13K
Scheduled
Jan 7
Form 4
—
0
$5.07
-$126,010.00
713.51K
Scheduled
Dec 7
Form 4
—
0
$7.88
-$59,980.80
512.14K
Scheduled
Nov 26
Form 4
—
0
$7.95
-$2,553.72
512.14K
Scheduled
Nov 19
Form 4
—
0
$5.84
-$145,180.00
713.51K
Scheduled
Nov 7
Form 4
—
0
$8.69
-$78,784.00
512.14K
Scheduled
Oct 18
Form 4
—
0
$7.89
-$196,419.85
713.51K
Scheduled
Oct 8
Form 4
—
0
$11.51
-$135,095.00
512.14K
Scheduled
Sep 18
Form 4
—
0
$9.67
-$240,971.25
713.51K
Scheduled
Sep 7
Form 4
—
0
$11.11
-$127,048.00
512.14K
Scheduled
Aug 20
Form 4
—
0
$9.04
-$225,143.75
713.51K
Scheduled
Aug 7
Form 4
—
0
$10.22
-$161,008.13
512.14K
Scheduled
Jul 18
Form 4
—
0
$9.38
-$233,577.50
713.51K
Scheduled
Jul 9
Form 4
—
0
$9.46
-$183,918.00
512.14K
Scheduled
Jun 18
Form 4
—
0
$8.78
-$170,420.99
713.51K
Scheduled
Jun 7
Form 4
—
0
$9.83
-$191,230.00
512.14K
Scheduled
May 18
Form 4
—
0
$8.52
-$165,107.00
713.51K
Scheduled
May 7
Form 4
—
0
$7.53
-$145,238.00
512.14K
Scheduled
Apr 18
Form 4
—
0
$6.37
-$122,189.00
713.51K
Scheduled
Apr 9
Form 4
—
0
$7.78
-$150,255.00
512.14K
Scheduled
Mar 19
Form 4
—
0
$8.21
-$158,823.00
713.51K
Scheduled
Mar 7
Form 4
—
0
$7.53
-$145,232.00
512.14K
Scheduled
Feb 20
Form 4
—
0
$6.38
-$122,408.00
713.51K
Scheduled
Feb 7
Form 4
—
0
—
—
0
Jan 24
Form 4
—
0
$5.18
-$98,242.00
512.14K
Scheduled
Jan 18
Form 4
—
0
$5.17
-$98,129.00
713.51K
Scheduled
Jan 8
Form 4
—
0
$4.71
-$88,913.00
512.14K
Scheduled
Dec 18
Form 4
—
0
$5.33
-$101,263.00
713.51K
Scheduled
Dec 7
Form 4
—
0
—
—
0
Jan 20
Form 4
—
0
—
—
0
Jan 15
Form 4
—
0
—
—
0
Jan 19
Form 4
-5.01%
-70.00K
$33.00
-$1,650,000.00
1.33M
Dec 1 - Jan 12
Form 4
-12.53%
-200.00K
$42.50
-$8,500,000.00
1.4M
Jul 2
Form 4
-1.24%
-20.00K
$41.76
-$835,158.00
1.6M
Scheduled
Jun 17 - Jun 18
Form 4
—
0
—
—
0
Dec 18
Form 4
+21.36%
132.57K
—
—
753.35K
Nov 12
Form 3
—
0
—
—
0
No matching records found

Acrivon Therapeutics, Inc. (ACRV) Snapshot price: $8.08

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Nov 14
Form 3
—
0
—
—
0
No matching records found